Q4 2024 EPS Estimates for CVS Health Co. (NYSE:CVS) Lowered by Analyst

CVS Health Co. (NYSE:CVS) – Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share estimates for shares of CVS Health in a report released on Wednesday, August 7th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $1.65 per share for the quarter, down from their previous forecast of $1.93. Leerink Partnrs currently has a “Market Perform” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $7.00 per share. Leerink Partnrs also issued estimates for CVS Health’s FY2026 earnings at $7.78 EPS and FY2027 earnings at $8.65 EPS.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.21 EPS.

CVS has been the topic of several other research reports. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. Robert W. Baird started coverage on shares of CVS Health in a report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 target price for the company. The Goldman Sachs Group reduced their price objective on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. TD Cowen cut CVS Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Finally, UBS Group cut shares of CVS Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. Twelve equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $73.24.

CVS Health Stock Performance

CVS opened at $55.82 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company’s fifty day moving average price is $59.28 and its two-hundred day moving average price is $65.90. The company has a market cap of $70.07 billion, a price-to-earnings ratio of 9.81, a PEG ratio of 0.57 and a beta of 0.52. CVS Health has a 1-year low of $52.77 and a 1-year high of $83.25.

Institutional Trading of CVS Health

Several hedge funds have recently bought and sold shares of CVS. Wedmont Private Capital lifted its stake in CVS Health by 0.8% in the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 146 shares during the last quarter. Bank of Stockton lifted its stake in CVS Health by 4.5% during the 1st quarter. Bank of Stockton now owns 3,467 shares of the pharmacy operator’s stock valued at $277,000 after acquiring an additional 150 shares during the period. Moody National Bank Trust Division grew its position in CVS Health by 0.7% during the 1st quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after purchasing an additional 150 shares during the period. Landmark Financial Advisors LLC raised its position in CVS Health by 3.8% during the fourth quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after acquiring an additional 153 shares in the last quarter. Finally, Garland Capital Management Inc. grew its stake in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after purchasing an additional 160 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.77%. CVS Health’s payout ratio is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.